Erytech Pharma S.A. (ERYP) Social Stream
ERYTECH PHARMA SA (ERYP) Price Targets From Analysts
Use the tables below to see what analysts covering ERYTECH PHARMA SA think about its future price and what recommendations they have for investors and traders.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-02 | 2 | $3.2 | $3.2 | $3.2 | $0.701 | 356.49% |
NA | 1 | $NA | $NA | $NA | $0.701 | NA% |
The Trend in the Analyst Price Target
Over the past 14 months, ERYP's average price target has gone down $19.42.
500 - Internal server error
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|
ERYP Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
3 | 0 | 0 | 2 | 0 | 0 | 2 |
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, ERYTECH PHARMA SA's number of analysts covering the stock is greater than 3.3% of them.
- ERYP has a lower variance in analysts' estimates than nearly 100% of all US stocks.
- To contextualize these metrics, consider that out of Healthcare stocks, ERYTECH PHARMA SA's average analyst price target is higher than 3.27% of them.
- To contextualize these metrics, consider that out of stocks in the small market cap category, ERYTECH PHARMA SA's upside potential (average analyst target price relative to current price) is higher than 72.48% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ERYTECH PHARMA SA are SLDB, XFOR, and APTO.
View All Top Stocks by Price Target
Is ERYP a Buy, Hold or Sell? See the POWR Ratings now!